DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 019219
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
The generic ingredient in BETAGAN is levobunolol hydrochloride. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
Summary for 019219
Tradename: | BETAGAN |
Applicant: | Allergan |
Ingredient: | levobunolol hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 019219
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 019219
Suppliers and Packaging for NDA: 019219
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BETAGAN | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019219 | NDA AUTHORIZED GENERIC | Pacific Pharma, Inc. | 60758-060 | 60758-060-05 | 1 BOTTLE, DROPPER in 1 CARTON (60758-060-05) > 5 mL in 1 BOTTLE, DROPPER |
BETAGAN | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019219 | NDA AUTHORIZED GENERIC | Pacific Pharma, Inc. | 60758-060 | 60758-060-10 | 1 BOTTLE, DROPPER in 1 CARTON (60758-060-10) > 10 mL in 1 BOTTLE, DROPPER |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.5% | ||||
Approval Date: | Dec 19, 1985 | TE: | AT | RLD: | Yes |
Expired US Patents for NDA 019219
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | BETAGAN | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019219-002 | Dec 19, 1985 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription